Discontinuing Specific Meds Linked to MS Relapse Risk Discontinuing Specific Meds Linked to MS Relapse Risk

In older patients with nonactive MS, there is a significant increased risk for relapse after discontinuing natalizumab and fingolimod, new research showed.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Source Type: news